Literature DB >> 6067027

Obstetrical problems coincidental to intrauterine transfusion for erythroblastosis.

R F Friesen.   

Abstract

In a series of 49 patients given 100 intrauterine transfusions for erythroblastosis numerous obstetrical problems were encountered which were not directly related to the procedure. The purpose of this paper is to describe the difficulties experienced and to consider why these could have been anticipated.All of the mothers endured considerable emotional strain. Complications, which in previous pregnancies contributed to producing their Rh sensitization, tended to recur. Deliveries were carried out between 26 and 35 weeks' gestation, at which stage induction was difficult and labour imperfect. In 24 cases the fetus was alive at the onset of labour. The other 25 cases presented the problems of intrauterine death, nine of which occurred in the dangerous second trimester.Because of the coincidental obstetrical problems and the difficulties inherent in intrauterine fetal transfusion, these cases should be managed only in centres equipped to deal with all possible complications.

Entities:  

Mesh:

Year:  1967        PMID: 6067027      PMCID: PMC1922762     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  3 in total

1.  THE TRANSPLACENTAL PASSAGE OF FOETAL RED BLOOD-CELLS AND THE PATHOGENESIS OF RH IMMUNISATION DURING PREGNANCY.

Authors:  A ZIPURSKY; J POLLOCK; P NEELANDS; B CHOWN; L G ISRAELS
Journal:  Lancet       Date:  1963-09-07       Impact factor: 79.321

2.  INTRAUTERINE TRANSFUSION OF FOETUS IN HAEMOLYTIC DISEASE.

Authors:  A W LILEY
Journal:  Br Med J       Date:  1963-11-02

3.  An unusual complication of intrauterine transfusion.

Authors:  C S Houston; A B Brown
Journal:  Can Med Assoc J       Date:  1966-06-11       Impact factor: 8.262

  3 in total
  1 in total

1.  Peritonitis, peritoneal adhesions and intestinal obstruction as a complication of intrauterine transfusion.

Authors:  L L De Veber; D G Marshall; M L Robinson
Journal:  Can Med Assoc J       Date:  1968-07-13       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.